3463 results for «2023大国工匠年度人物»
3463 results
How to support the equal advancement of women in interventional cardiology
18 May 2023 – From EuroPCR 2023
Roxana Mehran, Marta Bande and Emanuele Barbato tackle the issue of gender equity: how to create a more equitable environment for women interventional cardiologists, and how to support women in the field of interventional cardiology as a whole. They also discuss the key drivers of change...
The PECTUS trial, OCT for identification of vulnerable plaques and its impact on clinical outcomes
16 May 2023 – From EuroPCR 2023
Niels Van Royen and Lorenz Räber discuss a very emerging topic: the vulnerable plaque, and more specifically the related PECTUS Trial. They address the question of why vulnerable plaques should be detected and what can be done with the results, before looking at the study design...
Latest evidences and experiences on ultra-thin strut stenting
17 May 2023 – From EuroPCR 2023
Suhas Hardas, Anupam Jena and Rajneesh Kapoor discuss ultra-thin strut stent technology.
When do we really call the new-generation stents "ultra-thin strut strents"? Why do we need stents of this type? Which lesions, or which patients, will they be most useful and effective for?
Find out more about...
Durability of surgical and transcatheter valves, what do we know so far?
16 May 2023 – From EuroPCR 2023
We have significant new data that highlights the long-lasting effectiveness of transcatheter devices, which brings forth a promising possibility of them competing with surgical valves in the next generation. Take part in a discussion with Bernard Prendergast and Raj Makkar as they analyze the data available so far...
At PCR, it’s all about people!
17 May 2023
EuroPCR – the 2023 edition – has been prepared with a new Core Team. Indeed, Jean Fajadet and William Wijns invited three new Course Directors to join them in this role at the end of last year. It was all part of a general reorganisation of PCR’s structure, during...
Learnings and perspectives from the Asian STEMI Registry
16 May 2023 – From EuroPCR 2023
Deanna Khoo invites Paul Ong and Michael K. Y. Lee, the Principal Investigators of the study, to present the results of the BioFreedom Asian Registry, which focused on the management of STEMI patients in Asia.
Find out more about the study design, before discovering the main outcomes!
This interview...
EuroPCR 2025: RESIL-Card achieves a major milestone - The resilience tool is ready for pilot testing!
20 May 2025
Launched in December 2023 by our community through the ‘We CARE Alliance’ and co-funded by the EU4Health work programme, the mission of the RESIL-Card project is to ensure that essential healthcare services for people with cardiovascular (CV) diseases are maintained during crises. Specifically, the project aims to...
Introducing our recognised EuroPCR Networkers!
The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial
25 Oct 2023
Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...
Author
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation
27 Aug 2023
Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial
Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.
Note the assumptions in this article are based on the presentation...
Author
RENOVATE-COMPLEX-PCI: Intravascular imaging-guided versus angiography-guided procedural optimization in complex percutaneous coronary intervention
06 Mar 2023
Daniele Giacoppo reports the main results of the RENOVATE-COMPLEX-PCI trial presented by Joo-Yong Hahn, from the Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, in a Late-Breaking Trial session at the American College of Cardiology (ACC) 2023 / World...
Author
BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial
26 Aug 2023
Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.
BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...
Author
Empowering European Healthcare Systems: RESIL-Card, an EU4Health Project, Launches to Enhance Cardiovascular Care Resilience
19 Jan 2024
Paris, 18 January 2024: The consortium and supporting partners that make up the RESIL-Card project kick-started the venture on 1st December 2023.
The 3-year project received a funding grant from the European Commission under the EU4Health Work Programme to strengthen European healthcare systems in providing continuity of care for...
Pregnant women working in the cathlab
17 May 2023 – From EuroPCR 2023
Lynn Hinterbuchner welcomes Angeliki Kolyda, radiographer, in the PCR TV studio, in the heart of EuroPCR 2023, to talk about pregnancy in the cathlab. Should a woman really worry about working in a cathlab? If so, why? When exactly? How can she best protect herself?
Follow this...
What is the role of intra-coronary physiology in guiding complete revascularisation?
17 May 2023 – From EuroPCR 2023
Nicola Ryan and Roberto Diletti discuss strategies for complete revascularisation in patients with acute coronary syndrome, and more specifically patients presenting with STEMI and multivessel disease.
What impact does physiology have on the completeness of revascularisation? Should complete revascularisation be guided by physiology? How does it improve performance? In...
What is the role of intra-coronary physiology and imaging to guide left main bifurcation PCI?
17 May 2023 – From EuroPCR 2023
As Alejandro Travieso explains, physiology and imaging are complementary to achieve good assessment of left main PCI. Dejan Milasinovic adds that different imaging tools can be used in different patients, so practitioners may choose between OCT and IVUS, depending on their main target of interest.
Find out the specifics...
Patient selection for tricuspid intervention - the role of the right heart
30 Nov 2023 – From PCR London Valves 2023
Interviewed by Jörg Hausleiter, Rebecca Hahn and Philipp Lurz provide insight into the right heart's role in tricuspid procedures.
How can we best assess right heart function in patients so as to choose the most appropriate therapy for them? How TTE and TEE can help? How can...
What is the optimal aortic valve choice in the younger patient: transcatheter or surgery?
29 Nov 2023 – From PCR London Valves 2023
Follow the discussion between Darren Mylotte, Kentaro Hayashida and Ole De Backer to better understand the concept of "young patients" and what it exactly implies, and analyze how best to bring these specific patients to the end of their still potentially long life, by choosing the...
